Surrey E S, Schoolcraft W B
Colorado Center for Reproductive Medicine, Englewood, Colorado, USA.
Fertil Steril. 2000 Apr;73(4):667-76. doi: 10.1016/s0015-0282(99)00630-5.
To assess the efficacy of various controlled ovarian hyperstimulation (COH) regimens in the prior poor-responder patient preparing for assisted reproductive techniques.
English-language literature review.
PATIENT(S): Candidates for assisted reproductive techniques who had been defined as having a prior suboptimal response to standard COH regimens.
INTERVENTION(S): A variety of regimes are reviewed, including increased gonadotropin doses, change of gonadotropins, adjunctive growth hormone (GH), luteal phase (long) GnRH agonist (GnRH-a) initiation, early follicular phase (flare) GnRH-a initiation, low-dose luteal phase (ultrashort) GnRH-a initiation, progestin pretreatment, and microdose flare GnRH-a initiation.
MAIN OUTCOME MEASURE(S): Maximal serum E(2) levels, follicular development, dose, and duration of gonadotropin therapy, cycle cancellation rates, oocytes retrieved, embryos transferred, and clinical and ongoing pregnancy rates.
RESULT(S): A lack of uniformity in definition of the poor responder and of prospective randomized trials make data interpretation somewhat difficult. Of the varied strategies proposed, those that seem to be more uniformly beneficial are microdose GnRH-a flare and late luteal phase initiation of a short course of low-dose GnRH-a discontinued before COH.
CONCLUSION(S): No single regimen will benefit all poor responders. General acceptance of uniform definitions and performance of large-scale prospective randomized trials are critical. Development of a reliable precycle screen will allow effective differentiation among normal responders, poor responders, and those who will not conceive with their own oocytes.
评估不同的控制性卵巢刺激(COH)方案对准备接受辅助生殖技术的既往反应不良患者的疗效。
英文文献综述。
被定义为对标准COH方案既往反应欠佳的辅助生殖技术候选者。
综述了多种方案,包括增加促性腺激素剂量、更换促性腺激素、添加生长激素(GH)、黄体期(长效)促性腺激素释放激素激动剂(GnRH-a)启动、卵泡早期(激发)GnRH-a启动、低剂量黄体期(超短效)GnRH-a启动、孕激素预处理以及小剂量激发GnRH-a启动。
血清E(2)最高水平、卵泡发育、促性腺激素治疗的剂量和持续时间、周期取消率、取卵数、移植胚胎数以及临床妊娠率和持续妊娠率。
对反应不良者的定义缺乏一致性以及前瞻性随机试验的缺乏使得数据解读有些困难。在提出的各种策略中,似乎更一致有益的是小剂量GnRH-a激发方案以及在COH前停用的低剂量GnRH-a短疗程黄体晚期启动方案。
没有单一方案能使所有反应不良者受益。统一的定义被普遍接受以及进行大规模前瞻性随机试验至关重要。开发可靠的周期前筛查将有助于有效区分正常反应者、反应不良者以及那些不能用自身卵子受孕的人。